Noumea Biosciences
Boston, US · Founded 2022
Biotech
Founders & leadership
MB
Matthew BlumExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$300KraisedSep 2022 · 1 investors · BiotechnologyRule 506(b)
▶$300KraisedSep 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew BlumExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $300K
- Minimum investment
- $300K
- Proceeds to insiders
- $85K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.